VANGUARD GROUP INC 13D and 13G filings for Editas Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 2:30 pm Unchanged | 2024-09-30 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 6,679,450 8.090% | 0 (Unchanged) | Filing |
| 2024-11-04 11:57 am Sale | 2024-09-30 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 6,679,450 8.090% | -1,782,251 (-21.06%) | Filing |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 8,461,701 10.360% | 1,588,578 (+23.11%) | Filing |
| 2023-02-09 11:16 am Sale | 2022-12-30 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 6,873,123 10.000% | -454,919 (-6.21%) | Filing |
| 2022-03-09 08:44 am Purchase | 2022-02-28 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 7,328,042 10.690% | 654,145 (+9.80%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 6,673,897 9.760% | 849,011 (+14.58%) | Filing |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Editas Medicine, Inc. EDIT | VANGUARD GROUP INC | 5,824,886 9.340% | 1,257,270 (+27.53%) | Filing |